Skip to content
★ Sign in to follow
GC

Giulia C. Kennedy

Directeur Scientifique et Médical
Total declarations
144
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (56 ops.)
€11.1M

Latest filing published 08 Dec 2022 for Veracyte, INC., €26k.

Filing timeline

BuySale
Giulia C. Kennedy

Insider track record

Disclosed buys
0
Disclosed sells
56

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

Giulia C. Kennedy: trading record in brief

Giulia C. Kennedy (senior executive) discloses dealings in Veracyte, Inc. to SEC (Form 4). In total, 144 filings cover trades dated from 28 February 2019 to 6 December 2022.

The open-market record consists of 56 sales worth €11.1M, with no purchase. Outside the open market, there are 28 share grants and 60 option exercises. So far in 2022, the count stands at no purchases and 10 sales.

On 8 December 2022 came the latest disclosure, an open-market sale for €26k in Veracyte, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to Giulia C. Kennedy

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations18 total
  • ▼
    Chief Scientific & Med OfficerExecutivesVeracyte, Inc.
    27,652 USD21SEC
    1,023 shares@ US$27.032.9% of flowCommon StockSEC:0001384101-22-000157:0
  • ◆
    Chief Scientific & Med OfficerExecutivesVeracyte, Inc.
    29,373 USD9SEC
    1,008 shares@ US$29.143.1% of flowCommon StockSEC:0001384101-22-000155:0
  • ◇
    Chief Scientific & Med OfficerExecutivesVeracyte, Inc.
    29 USD9SEC
    2 shares@ US$14.340.0% of flowCommon StockSEC:0001384101-22-000145:0
  • ▼
    Chief Scientific & Med OfficerExecutivesVeracyte, Inc.
    25,575 USD21SEC
    1,023 shares@ US$25.002.9% of flowCommon StockSEC:0001384101-22-000141:0
  • ◆
    Chief Scientific & Med OfficerExecutivesVeracyte, Inc.
    19,333 USD9SEC
    1,008 shares@ US$19.182.2% of flowCommon StockSEC:0001384101-22-000131:0
  • ◆
    Chief Scientific & Med OfficerExecutivesVeracyte, Inc.
    0SEC
    10,702 shares0Common StockSEC:0001384101-22-000113:0
  • ◆
    Chief Scientific & Med OfficerExecutivesVeracyte, Inc.
    18,376 USD16SEC
    1,008 shares@ US$18.230.0006% mcap2.1% of flowCommon StockSEC:0001384101-22-000074:0
  • ◆
    Chief Scientific & Med OfficerExecutivesVeracyte, Inc.
    0SEC
    42,412 shares0Common StockSEC:0001384101-22-000054:0
  • ◆
    Chief Scientific & Med OfficerExecutivesVeracyte, Inc.
    0SEC
    42,412 shares0Common StockSEC:0001384101-22-000046:0
  • ◆
    Chief Scientific & Med OfficerExecutivesVeracyte, Inc.
    287,782 USD15SEC
    10,337 shares@ US$27.8440.4% of flowCommon StockSEC:0001384101-22-000040:0
  • ◇
    Chief Scientific & Med OfficerExecutivesVeracyte, Inc.
    26,348 USD11SEC
    4,406 shares@ US$5.983.6% of flowCommon StockSEC:0001384101-21-000180:0
  • ◆
    Chief Scientific & Med OfficerExecutivesVeracyte, Inc.
    35,769 USD11SEC
    912 shares@ US$39.224.9% of flowCommon StockSEC:0001384101-21-000176:0
  • ◆
    Chief Scientific & Med OfficerExecutivesVeracyte, Inc.
    7,718 USD11SEC
    149 shares@ US$51.801.0% of flowCommon StockSEC:0001384101-21-000161:0
  • ◇
    Chief Scientific & Med OfficerExecutivesVeracyte, Inc.
    26,348 USD11SEC
    4,406 shares@ US$5.983.5% of flowCommon StockSEC:0001384101-21-000155:0
  • ◆
    Chief Scientific & Med OfficerExecutivesVeracyte, Inc.
    48,309 USD12SEC
    912 shares@ US$52.976.4% of flowCommon StockSEC:0001384101-21-000150:0
  • ◇
    Chief Scientific & Med OfficerExecutivesVeracyte, Inc.
    108,019 USD12SEC
    4,375 shares@ US$24.6914.2% of flowCommon StockSEC:0001384101-21-000116:0
  • ◇
    Chief Scientific & Med OfficerExecutivesVeracyte, Inc.
    26,348 USD11SEC
    4,406 shares@ US$5.983.4% of flowCommon StockSEC:0001384101-21-000101:0
  • ◆
    Chief Scientific & Med OfficerExecutivesVeracyte, Inc.
    32,896 USD11SEC
    912 shares@ US$36.074.2% of flowCommon StockSEC:0001384101-21-000096:0

18 of 18 declarations